About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Prostate CancerTennessee

Prostate Cancer Clinical Trials in Tennessee

Find 386 clinical trials for prostate cancer near Tennessee. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 386 trials

CompletedSurgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerRATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells.NCT00023686·Little Rock, Arkansas and 35 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerThis study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a…NCT04666129·Tucson, Arizona and 15 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 175 others

CompletedA Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateThe purpose of this study is to collect follow-up safety data from participants in completed abiraterone acetate studies for a maximum duration of 9 years.NCT01517802·Aurora, Colorado and 21 others

TerminatedAnalysis of Cell-free DNA (cfDNA) in Men With Elevated PSA LevelsThis is a multi-centre prospective study in which blood samples will be taken from 1500 male patients aged between 21-80 scheduled for prostate biopsy.NCT02771769·Baltimore, Maryland and 1 other

RecruitingJUR-003 in Adult Patients With Metastatic Prostate CancerJUR-003-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of…NCT07824349·Grand Rapids, Michigan and 3 others

CompletedAndrogen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation therapy may stop the adrenal glands from making androgens.NCT00309985·Anchorage, Alaska and 342 others

CompletedAssessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsThe objective of this hybrid effectiveness-implementation study is to examine the effects of an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate…NCT03935282·Fort Smith, Arkansas and 11 others

TerminatedAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesThis was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups.NCT02431260·Los Angeles, California and 11 others

CompletedA Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate CancerThis is a randomized, open-label study designed to assess the effects of sipuleucel-T when administered concurrently or sequentially with enzalutamide.NCT01981122·Tucson, Arizona and 18 others

Completed177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate CancerThe purpose of this study is to determine whether 177Lu-PSMA-617 improves the Radiographic progression-free survival (rPFS) or Overall Survival (OS) compared to a change in…NCT04689828·Denver, Colorado and 71 others

RecruitingInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000…NCT03151629·Birmingham, Alabama and 120 others

Active not recruitingStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCThe purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in…NCT04821622·Birmingham, Alabama and 311 others

CompletedPhase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate CancerThe purpose of this study is to evaluate how safe PS-341(VELCADE) is when given with Docetaxel (Taxotere) to patients with androgen-independent prostate cancer, and also to see…NCT00064610·Los Angeles, California and 3 others

CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

CompletedProstate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic…NCT00106691·Huntsville, Alabama and 137 others

TerminatedA Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate CancerThis is a global, multi-center, open-label, randomized phase 1b/2, active-controlled safety and efficacy study of oral administration of tazemetostat in combination with…NCT04179864·San Diego, California and 23 others

CompletedPhase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor TumorsThis is a first time in man (FTIM), Phase I study to determine the Maximum Tolerated Dose, Recommended Phase 2 Dose, safety, tolerability and Pharmacokinetics of AZD5312.NCT02144051·Sarasota, Florida and 3 others

Active not recruitingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1)…NCT04521686·Phoenix, Arizona and 32 others

UnknownA Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of JBI-802 in patients with Advanced Solid Tumors.The efficacy of…NCT05268666·Denver, Colorado and 3 others

PreviousPage 9 of 20Next

Other Conditions in Tennessee

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma